An Early Phase Study of Abraxane Combined With Phenelzine Sulfate in Patients With Metastatic or Advanced Breast Cancer
Clinical trial NCT03505528 · COMPLETED
Trial details
- NCT number
- NCT03505528
- Sponsor
- EpiAxis Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-17
- Primary completion
- 2019-10-30
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.